Analyst Ratings for Biogen Inc. (BIIB)Updated: 2017-07-28
An average rating of Overweight has been given to Biogen Inc. (NASDAQ:BIIB) by analysts covering the stock. A consensus rating of Overweight was previously issued for BIIB last month.
30 analysts issued ratings on the stock, where 16 gave BIIB a buy rating, 3 gave an overweight rating, 11 gave a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. During this time, the number of analysts bearish on the stock has decreased by 1.
Investment analysts gave a few price targets for BIIB. The most optimistic analyst gave a price target of 442, which equates to a potential upside of 53.5 percent. The most pessimistic price target was 270, implying potential capital losses of -6.23 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.
Analysts have revised their earnings estimates upwards for this quarter, by about 0.47 percent on average, compared to last month. That number becomes 0.47 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised upwards by 1.59 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 1.34 percent in FY estimates.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 9 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. Over the same time period, 4 analysts revised their FY earnings estimates upwards, while 0 analysts made negative revisions to their fiscal year's estimates.
BIIB has an estimated earnings growth rate of 35.26 percent as forecasted by analysts. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. BIIB has a PEG ratio of 0.54.
BIIB has a 52-week high of 307.33 and a 52-week low of 244.28. The current market price is above the trailing year's low by 17.88 percent, and below the high by 6.31 percent. BIIB has a price/earnings ratio of 18.91. Investors typically compare the P/E ratio to a company's peers in the industry. The BIIB value stock report compares BIIB to some of its peers using value stock charts. The stock has a market capitalization of $63.15 billion. BIIB's next earnings release will be on 0000-00-00, which is days away.